Back to AVBP
General Catalyst Group Management, LLC → AVBP
General Catalyst Group Management, LLC AVBP Position History
ArriVent BioPharma, Inc. • Healthcare
Quarters held
4
Latest value
$45.3M
Q3 2026
Peak value
$51.9M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $30.1M |
| Q1 2026 | $34.5M |
| Q2 2026 | $51.9M |
| Q3 2026 | $45.3M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $45.3M | 1.49M | — | — |
| Q2 2026 | $51.9M | 1.49M | — | — |
| Q1 2026 | $34.5M | 1.49M | — | — |
| Q4 2025 | $30.1M | 1.49M | — | — |
Other funds holding AVBP
$156.9M
$149.1M
$136.5M
$119M
$105.2M
$101.5M